GlaxoSmithKline PLCGSK:LSE

Add to portfolio
Set alert
Interactive chart
Historical prices
Data definitions
1,742
31.00 / 1.75%
7.69m
25.19%
0.4413
Close in GBXToday's changeShares traded1 year changeBeta
As of May 23 2013 16:56 BST.Data delayed by at least 15 minutes.
Overview
Balance sheet
Cash flow
Income statement
See more company Information on this page. Log in or Register for free now
In millions of GBP (except for per share items)
Annual data
Interim data
Fiscal data as of Dec 31 2012201220112010
OPERATIONS
Net income4,7445,4581,853
Depreciation/depletion8718931,146
Non-Cash items2,8542,6472,385
Cash taxes paid, supplemental1,6731,4631,834
Cash interest paid, supplemental779769775
Changes in working capital(4,668)(3,278)880
Total cash from operations4,3756,2506,797
INVESTING
Capital expenditures(1,520)(1,328)(1,635)
Other investing and cash flow items, total(1,111)1,216(233)
Total cash from investing(2,631)(112)(1,868)
FINANCING
Financing cash flow items(1,000)(893)(1,094)
Total cash dividends paid(3,814)(3,406)(3,205)
Issuance (retirement) of stock, net(2,116)(1,932)63
Issuance (retirement) of debt, net3,579(1.00)(1,335)
Total cash from financing(3,351)(6,232)(5,571)
NET CHANGE IN CASH
Foreign exchange effects(92)(108)81
Net change in cash(1,699)(202)(561)
Net cash-begin balance/reserved for future use5,6055,8076,368
Net cash-end balance/reserved for future use3,9065,6055,807
SUPPLEMENTAL INCOME
Depreciation, supplemental8718931,146
Cash interest paid, supplemental779769775
Cash taxes paid, supplemental1,6731,4631,834
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.